サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266534

遺伝子合成の世界市場：方法別、エンドユーザー別：機会分析と産業予測、2021-2031年

Gene Synthesis Market By Method, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 280 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
遺伝子合成の世界市場：方法別、エンドユーザー別：機会分析と産業予測、2021-2031年
出版日: 2023年02月01日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子合成の世界市場規模は2021年に11億1,000万米ドルで、2031年には59億7,900万米ドルの売上を計上し、CAGR18.4%で成長すると予測されています。

遺伝子合成は、人工遺伝子を生成または生産するための科学的方法です。遺伝子合成は、ヌクレオチドから遺伝子を組み立て、構築することを目的とした様々な方法を用いて遺伝子を作成するプロセスを指します。ヌクレオチドは、核酸を作る過程で不可欠な構成要素です。

実際には、RNAやDNAはヌクレオチドの長い配列でできています。これらの化学物質は、リン酸塩と窒素を含む塩基に結合した糖分子からできています。遺伝子合成技術により、科学者や研究者は所望の配列を正確に指定し、調整することができます。

老人人口の増加、慢性疾患の発生率の上昇、費用対効果の高い治療、新規ワクチン需要の増加は、遺伝子合成市場の成長を促進すると予想される主な要因の一部です。世界中で感染症が流行しているため、効果的な治療法やワクチンに対する需要が高まり、研究者や科学者は研究努力を加速させ、がんや腫瘍などの病気に対する効果的な治療法を生み出す必要に迫られています。特定の病気は、化学薬品や遺伝子治療のような生物学的治療で効果的に治療することができます。ゲノミクスの応用により、風土病や感染症の治療が強化されました。また、新薬の耐性についてより深く理解し、ワクチンや新薬の標的となりうるものを特定することができます。遺伝子治療は、組換えDNA技術、DNA＆RNAリボザイム、一本鎖抗体などで治療できるため、感染症の治療において多くの研究者の関心を集めています。

遺伝子治療技術の急速な進化に伴い、患者の遺伝子挿入や遺伝子治療の実施には、より高度な技術と経験豊富な人材が必要とされています。ほとんどのヘルスケア専門家が治療を実行できないことは、予測期間を通じて遺伝子合成市場にマイナスの影響を与える可能性があります。

新しい遺伝子の合成を含む研究に対する政府支援の増加、治療効率の向上、研究者、科学者、製薬・バイオテクノロジー企業による研究開発の拡大が、今後の市場成長を促進すると予想されます。さらに、開発された新技術による治療の恩恵を一人一人が受けられるようにするための償還政策により、今後数年間で市場の成長は加速すると予想されます。これが、遺伝子合成市場の成長に寄与しています。

COVID-19のパンデミックは、遺伝子合成産業にプラスとマイナスの両面から影響を与えています。パンデミックの初期段階では、コロナウイルス2019（COVID-19）により、材料の供給、生産、物流業務に大きな課題が生じ、細胞・遺伝子治療（CGT）事業に大きな影響を与えました。COVID-19の流行が始まると、世界中のほとんどの企業や研究機関が操業を停止し、遺伝子合成装置の市場需要や研究室での使用量が減少しました。

COVID-19の流行は、遺伝子合成ビジネスに大きな成長の可能性をもたらしています。遺伝子合成は未知の可能性を秘めたテーマであり、それが収益創出という点で市場の成長を支えています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • トップインパクトファクター
    • トップインベストメントポケット
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19市場への影響度分析
  • 主要レギュレーション分析
  • 市場シェア分析
  • 特許の情勢
  • 規制ガイドライン
  • バリューチェーン分析

第4章 遺伝子合成市場：手法別

  • 概要
    • 市場規模・予測
  • 固相合成
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • PCR法別酵素の合成
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • CHIP別DNA合成
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第5章 遺伝子合成市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 学術・研究機関、
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • バイオテクノロジーと製薬会社、
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 診断ラボラトリー
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第6章 遺伝子合成市場：地域別

  • 概要
    • 市場規模・予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模・予測：メソッド別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 米国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • カナダ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • メキシコ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模・予測：メソッド別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 英国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • ドイツ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • フランス
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • スペイン
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • イタリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • その他欧州
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
  • アジア太平洋地域
    • 主な動向と機会
    • 市場規模・予測：メソッド別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 中国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • インド
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • 日本
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • 韓国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • オーストラリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
  • LAMEA
    • 主な動向と機会
    • 市場規模・予測：メソッド別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ブラジル
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • サウジアラビア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • UAE
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • 南アフリカ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別
      • LAMEAの残りの地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：メソッド別
      • 市場規模・予測：エンドユーザー別

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第8章 企業プロファイル

  • Genscript Technology
  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 02. GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 03. GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 04. GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 05. GLOBAL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 06. GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 07. GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 08. GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 09. GENE SYNTHESIS MARKET FOR OTHER, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 10. GENE SYNTHESIS MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 11. NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 12. NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 13. NORTH AMERICA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 14. U.S. GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 15. U.S. GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 16. CANADA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 17. CANADA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 18. MEXICO GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 19. MEXICO GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 20. EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 21. EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 22. EUROPE GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 23. UK GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 24. UK GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 25. GERMANY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 26. GERMANY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 27. FRANCE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 28. FRANCE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 29. SPAIN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 30. SPAIN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 31. ITALY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 32. ITALY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 33. REST OF EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 34. REST OF EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 35. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 36. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 37. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 38. CHINA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 39. CHINA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 40. INDIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 41. INDIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 42. JAPAN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 43. JAPAN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 44. SOUTH KOREA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 45. SOUTH KOREA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 46. AUSTRALIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 47. AUSTRALIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 48. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 49. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 50. LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 51. LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 52. LAMEA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 53. BRAZIL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 54. BRAZIL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 55. SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 56. SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 57. UAE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 58. UAE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 59. SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 60. SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 61. REST OF LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 62. REST OF LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
  • TABLE 63. GENSCRIPT TECHNOLOGY: KEY EXECUTIVES
  • TABLE 64. GENSCRIPT TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 65. BROOKS AUTOMATION, INC.: KEY EXECUTIVES
  • TABLE 66. BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT
  • TABLE 67. BOSTER BIOLOGICAL TECHNOLOGY: KEY EXECUTIVES
  • TABLE 68. BOSTER BIOLOGICAL TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 69. TWIST BIOSCIENCE: KEY EXECUTIVES
  • TABLE 70. TWIST BIOSCIENCE: COMPANY SNAPSHOT
  • TABLE 71. CODEX DNA: KEY EXECUTIVES
  • TABLE 72. CODEX DNA: COMPANY SNAPSHOT
  • TABLE 73. BIOMATIK: KEY EXECUTIVES
  • TABLE 74. BIOMATIK: COMPANY SNAPSHOT
  • TABLE 75. PROMAB BIOTECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 76. PROMAB BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 77. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 78. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 79. INTEGRATED DNA TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 80. INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 81. ORIGENE TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 82. ORIGENE TECHNOLOGIES, INC.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF GENE SYNTHESIS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN GENE SYNTHESIS MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALGENE SYNTHESIS MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: GENE SYNTHESIS MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: GENE SYNTHESIS MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: GENE SYNTHESIS MARKET
  • FIGURE 16. GENE SYNTHESIS MARKET, BY METHOD, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. GENE SYNTHESIS MARKET, BY END USER, 2021(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GENE SYNTHESIS MARKET FOR OTHER, BY COUNTRY 2021-2031(%)
  • FIGURE 25. GENE SYNTHESIS MARKET BY REGION, 2021
  • FIGURE 26. U.S. GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 27. CANADA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 28. MEXICO GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 29. UK GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 30. GERMANY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 31. FRANCE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 32. SPAIN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 33. ITALY GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 34. REST OF EUROPE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 35. CHINA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 36. INDIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 37. JAPAN GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 38. SOUTH KOREA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 39. AUSTRALIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 40. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 41. BRAZIL GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 42. SAUDI ARABIA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 43. UAE GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 44. SOUTH AFRICA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 45. REST OF LAMEA GENE SYNTHESIS MARKET, 2021-2031 ($THOUSAND)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: GENE SYNTHESIS MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2021
目次
Product Code: A39015

The global gene synthesis market size was $1,110 million in 2021 and is predicted to grow with a CAGR of 18.4%, by generating a revenue of $5,979 million by 2031.

Gene synthesis is the scientific method for generating or producing artificial genes. Gene synthesis refers to the process by which genes are created using various ways aimed at assembling and constructing genes from nucleotides. Nucleotide is an essential building block in the process of creating nucleic acid. 

In reality, RNA and DNA are made up of lengthy sequences of nucleotides. These chemicals are made up of sugar molecules coupled to a phosphate and a nitrogen-containing base. The gene synthesis technique enables scientists and researchers to precisely specify and tailor the desired sequence. 

The increase in the geriatric population, rise in the incidence of chronic illnesses, cost-effective treatment, and increase in demand for novel vaccines are some of the primary factors anticipated to drive the gene synthesis market growth. Because of the rising prevalence of infectious diseases around the world, the demand for effective treatments and vaccines has increased, prompting researchers and scientists to accelerate their research efforts and produce effective treatment options for diseases such as cancer and tumors. Certain illnesses can be effectively treated with chemical drugs and biological treatments, such as gene therapy. The application of genomics has enhanced the treatment of endemic and infectious diseases. It also allows us to better understand new drug resistance and identify possible targets for vaccines and new medicines. Gene therapy has piqued the interest of many researchers for the treatment of infectious diseases since it can be treated with recombinant DNA technology, DNA & RNA ribozyme, and single chain antibodies.  

The rapid evolution of the technology involved in gene therapy necessitates increased skill work and experienced individuals for the insertion of genes or the execution of gene therapy procedures in patients. Most healthcare professionals' inability to carry out the therapy may have a negative impact on the gene synthesis market throughout the forecast period. 

Increase in government support for the research involving synthesis of new genes,  rise in therapy efficiency, and growth in research and development by the researchers, scientists, and pharmaceutical & biotechnological companies is expected to drive the market growth in the future. In addition, the market growth is expected to boost in the coming years owing to reimbursement policies so that every individual can benefit from the treatment of new technologies developed. This contributes to the rise in the gene synthesis market. 

The COVID-19 pandemic has had an impact on the gene synthesis industry, both positively and negatively. During the initial phase of the pandemic, the coronavirus 2019 (COVID-19), which has caused significant challenges in the supply of materials, production, and logistical operations, significantly impacted the cell and gene therapy (CGT) business. When the COVID-19 pandemic began, most businesses and research initiatives around the world suspended operations, reducing market demand for gene synthesizers and their use in laboratories. 

The spread of the COVID-19 pandemic has aided the gene synthesis business by creating enormous growth possibilities. The topic of gene synthesis is being investigated for undiscovered potential, which is supporting the growth of the market in terms of revenue creation. 

The key players profiled in this report include: Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc. 

The gene synthesis market is segmented on the basis of method, end user, and region. As per method, the market has been divided into solid phase synthesis, PCR-based enzyme synthesis, and CHIP-based DNA synthesis. By end user, the market has been classified into academic and research institutes, biotech and pharmaceutical companies, diagnostic laboratories, and other. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gene synthesis market analysis from 2021 to 2031 to identify the prevailing gene synthesis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the gene synthesis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global gene synthesis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Method

  • Solid Phase Synthesis
  • PCR Based Enzyme Synthesis
  • CHIP Based DNA Synthesis

By End User

  • Biotech and Pharmaceutical Companies,
  • Diagnostic Laboratories
  • Academic and Research Institutes,
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience
  • Codex DNA
  • Biomatik
  • promab biotechnologies, inc.
  • Thermo Fisher Scientific, Inc.
  • Genscript Technology
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Key Regulation Analysis
  • 3.7. Market Share Analysis
  • 3.8. Patent Landscape
  • 3.9. Regulatory Guidelines
  • 3.10. Value Chain Analysis

CHAPTER 4: GENE SYNTHESIS MARKET, BY METHOD

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Solid Phase Synthesis
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. PCR Based Enzyme Synthesis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. CHIP Based DNA Synthesis
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: GENE SYNTHESIS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Academic and Research Institutes,
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Biotech and Pharmaceutical Companies,
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Other
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: GENE SYNTHESIS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Method
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Method
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Method
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Method
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Method
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. UK
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Method
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. Germany
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Method
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. France
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Method
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Method
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Method
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Method
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Method
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Method
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. India
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Method
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Method
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Method
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Method
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Method
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Method
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Method
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Method
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. UAE
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Method
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Method
      • 6.5.4.4.3. Market size and forecast, by End User
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Key market trends, growth factors and opportunities
      • 6.5.4.5.2. Market size and forecast, by Method
      • 6.5.4.5.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Genscript Technology
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
  • 8.2. Brooks Automation, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
  • 8.3. Boster Biological Technology
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
  • 8.4. Twist Bioscience
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
  • 8.5. Codex DNA
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
  • 8.6. Biomatik
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
  • 8.7. promab biotechnologies, inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
  • 8.8. Thermo Fisher Scientific, Inc.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
  • 8.9. Integrated DNA Technologies, Inc.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
  • 8.10. OriGene Technologies, Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot